Resources


ASAP reduces costs to a fraction of conventional stability studies…

September 29, 2017
#ASAPprime® and Stability Modeling #FreeThink in the News

The American Pharmaceutical Review recently published an article in their July/August 2017 issue titled, “An Introduction to the Accelerated Stability Assessment Program (ASAP).” The article concludes that ASAP is “much faster than conventional stability or package screening studies at a higher accuracy.” And that “ASAP is capable of reducing costs to a fraction of conventional […]

Continue Reading

Save the Date! SOS 2018 Boston

September 22, 2017
#Events #Science of Stability (SOS) Conference #Stability Conference

Don’t miss the 2018 Science of Stability Conference, SOS 2018 Boston.  Some 100 delegates registered for the SOS 2017 in Dublin, Ireland 3-5 October.  With such strong attendance this year, SOS 2018 Boston is expected to sell out.  Sign up to receive conference updates here.

Continue Reading

Stability Modeling and Package Selection

September 7, 2017
#ASAPprime® and Stability Modeling #Packaging

To save time and get to market faster, pharmaceutical manufacturers use computer modeling and simulations that assess product stability and propose packaging options. FreeThink’s ASAPprime® accelerated stability software is the premier scientific software package for rapid data modeling of product shelf-life. See the full article, in Tablets & Capsules (www.TabletsCapsules.com) titled, “Stability Modeling and Package […]

Continue Reading

ASAPprime in July 2017 Issue of AAPS Newsmagazine

July 12, 2017
#Customer Presentation/ Publications using ASAPprime® #FreeThink in the News

AAPS.org and the July 2017 issue of AAPS Newsmagazine recently published an article on FreeThink’s ASAPprime® accelerated stability software titled, “Predicting Drug Dissolution with ASAPprime®” AAPS Open editor-in-chief, Christopher M. Riley, Ph.D., coauthored and presented research on using ASAPprime® software to predict changes in drug dissolution from an immediate-release tablet containing two active pharmaceutical ingredients using […]

Continue Reading

Registration Now Open! Science of Stability (SOS) Conference – SOS 2017

July 12, 2017
#Science of Stability (SOS) Conference #Stability Conference

Registration for the 3rd annual Science of Stability Conference – SOS 2017 is Now Open! Early Bird Discount through July 31, 2017

Continue Reading

Science of Stability Conference (SOS) 2016 Presentations

February 6, 2017
#Science of Stability (SOS) Conference #Stability Conference

  The 2016 Science of Stability Presentations:   Alisa Waterman, Ph.D.  “Accelerated Stability of Peptides” Bryan S. Wick Ph.D. “Applications of ASAP in Generics Industry” Daniel Burnett Ph.D. “Understanding Importance of Water Sorption Isotherm Shape, Hysteresis  and Models on Pharmaceutical Materials”   Part 1 and Part 2 Elke Debbie and Helen Williams (Regulatory Sub-Team) – “IQ Risk […]

Continue Reading

Stabilization of Pharmaceuticals to oxidative degradation

February 6, 2017
#ASAPprime® and Stability Modeling

A guide for stabilization of pharmaceuticals to oxidation is presented as a guide for formulators. Click here to access the document.

Continue Reading

Hydrolysis in Pharmaceutical formulations

February 6, 2017
#ASAPprime® and Stability Modeling

A literature review of hydrolysis in active pharmaceutical ingredients and the effects on dosage form stability due to hydrolysis of excipients. Click here to access the document.

Continue Reading

Use of Oxygen Scavengers to Stabilize Solid Pharmaceutical Dosage Forms: A Case Study

February 6, 2017
#ASAPprime® and Stability Modeling

A case study is described where degradation of solid pharmaceutical dosage form susceptible to oxidation is minimized by incorporation of oxygen scavenger as part of packaging. Click here to gain access to document.

Continue Reading

Impurities in Drug Products: Handbook of Isolation and Characterization of Impurities in Pharmaceuticals, Volume 5

February 6, 2017
#ASAPprime® and Stability Modeling

  An overview focused on those impurities brought into drug product system by excipients or dosage form processing likely to cause stability or performance issues in the dosage form. Click here to access document.

Continue Reading